Comparison Chart Bolt Biotherapeutics, Inc.
Stocks
BOLT
US0977022039
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.770 USD | +7.67% |
|
+0.21% | -12.77% |
| 05-12 | Bolt Biotherapeutics reports first quarter 2026 financial results | RE |
| 05-12 | Bolt Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Bio Therapeutic Drugs | +7.67% | +0.21% | -12.77% | -26.95% | -98.54% | 9.17M |  | | |
- Stock Market
- Stocks
- BOLT Stock
- Charts Bolt Biotherapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition